IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 7 holdings | $244.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$99.5K5,104,13040.7%
Pliant Therapeutics, Inc.(PLRX)COM729139105$46.8K5,839,16019.1%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$37.8K6,391,17615.4%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$24.4K1,922,54910.0%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$19.4K3,962,2027.9%
Decibel Therapeutics, Inc.COM24343R106$13.2K3,139,6855.4%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$3.5K1,148,7801.4%